Impact of donepezil treatment for Alzheimer's disease on caregiver time

Author： Wimo Anders   Winblad Bengt   Shah Sonali N.   Chin Warren   Zhang Richard   McRae Thomas  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.20, Iss.8, 2004-08, pp. : 1221-1225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 47, Iss. 5, 1999-05 ,pp. : 570-578

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Profile of Donepezil in the Treatment of Alzheimer’s Disease

By  

Gerontology, Vol. 45, Iss. 1, 1999-01 ,pp. : 23-32

Karger

Access to resources Recommend Favorite

Donepezil in Alzheimer's disease: a clinical observational study evaluating individual treatment response

By Riepe Matthias W.   Kohler Jürgen   Horn Rolf  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1829-1835

Informa Healthcare

Access to resources Recommend Favorite

Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials

By Winblad Bengt   Black Sandra E.   Homma Akira   Schwam Elias M.   Moline Margaret   Xu Yikang   Perdomo Carlos A.   Swartz Jina   Albert Kenneth  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2577-2587

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy

By Sakka Paraskevi   Tsolaki Magda   Hort Jakub   Hager Klaus   Soininen Hilkka   López Pousa Secundino   Li Chunming   Schwam Elias  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3153-3165

Informa Healthcare

Access to resources Recommend Favorite